RAD1 and Burkitt lymphoma: In REC-1 (MCL) and Daudi (Burkitt lymphoma) cell lines, FPFT-2216 showed growth-inhibitory activity similar to that of the A/I-degrader iberdomide, suggesting that A/I degradation may also be cytostatic in lymphoma cell lines, such as MCL and BL.